MDNA Life Sciences, Inc.
Diagnostic tests using molecular analysis to identify cancer risk and disease status
- Sector
- Medtech
- Headquarters
- West Palm Beach, FL
- Founded
- 2014
- Latest Form D
- $470K, Jan 2019
- Total capital
- $1.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.2M
- 4 Form D · last Jan 2019
- 93 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 8 pending · first 2017
- Rank in peer group#22 of 160
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$470K
- Private capital raisedForm D · SEC · 3rd filing$228K
- Private capital raisedForm D · SEC · 2nd filing$410K
- Private capital raisedForm D · SEC · 1st filing$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 160 peers
Line = medianMedtech · Instrument
- Granted patents#22 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Andrew HarbottleExecutive OfficerNamed in SEC Form D filings
- Anthony CantoneDirectorNamed in SEC Form D filings
- Chris MittonExecutive OfficerNamed in SEC Form D filings
- Christopher HillDirectorNamed in SEC Form D filings
- Christopher MittonExecutive OfficerNamed in SEC Form D filings
- George SteinfelsExecutive Officer, DirectorNamed in SEC Form D filings
Show all 12 people
- Harry SmartDirectorNamed in SEC Form D filings
- Jennifer CreedExecutive OfficerNamed in SEC Form D filings
- Peter McKenneyExecutive OfficerNamed in SEC Form D filings
- Robert BoxerDirectorNamed in SEC Form D filings
- Robert PoulterExecutive OfficerNamed in SEC Form D filings
- Robert ThayerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 14- PendingMitochondrial Dna Deletions Associated With EndometriosisUSPTOApplication 17415507
- Granted3.4 Kb Mitochondrial Dna Deletion For Use In The Detection Of CancerUSPTOUS 11,111,546
- GrantedMitochondrial Mutations And Rearrangements As A Diagnostic Tool For The Detection Of Sun Exposure, Prostate Cancer And Other CancersUSPTOUS 10,907,213
Show all 14 patent records
- Mitochondrial Dna Deletions Associated With EndometriosisAug 11, 2022 · Application 17415507Pending
- 3.4 Kb Mitochondrial Dna Deletion For Use In The Detection Of CancerSep 7, 2021 · US 11,111,546Granted
- Mitochondrial Mutations And Rearrangements As A Diagnostic Tool For The Detection Of Sun Exposure, Prostate Cancer And Other CancersFeb 2, 2021 · US 10,907,213Granted
- Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancerDec 19, 2019 · Application 16558108Pending
- Aberrant Mitochondrial Dna, Associated Fusion Transcripts And Hybridization Probes ThereforDec 19, 2019 · Application 16386381Pending
- Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancerSep 3, 2019 · US 10,400,290Granted
- 3.4 Kb Mitochondrial Dna Deletion For Use In The Detection Of CancerJun 4, 2019 · US 10,308,987Granted
- Aberrant Mitochondrial Dna, Associated Fusion Transcripts And Hybridization Probes ThereforApr 23, 2019 · US 10,266,899Granted
- UV Associated mtDNA Fusion Transcripts and Methods and Uses ThereofDec 6, 2018 · Application 16057052Pending
- Mitochondrial Mutations And Rearrangements As A Diagnostic Tool For The Detection Of Sun Exposure, Prostate Cancer And Other CancersAug 29, 2017 · US 9,745,632Granted
- UV Associated mtDNA Fusion Transcripts and Methods and Uses ThereofJun 22, 2017 · Application 15347601Pending
- Mitochondrial DNA Deletions Associated with EndometriosisApplication 62784403Pending
- Mitochondrial DNA Deletions Associated with EndometriosisApplication 62931173Pending
- Mitochondrial Dna Deletions Associated With EndometriosisApplication PCTUS2019068098Pending
Related companies, and why
- OTU Medical Inc.Similar federal contract value in Medtech · null in contracts
- FEMTOVOX INCORPORATEDSimilar federal contract value in Medtech · null in contracts
- Linear Dimensions Semiconductor Inc.Similar federal contract value in Medtech · null in contracts
- Major Medical Devices, LLCSimilar federal contract value in Medtech · null in contracts
- Resonant Link Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Platform Innovations Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .